U.S. CRISPR Gene Detection and Diagnostic Market to 2032
Overview
The U.S. CRISPR Gene Detection and Diagnostic Market is expected to reach a 2,732.61 USD Million by 2032 and is projected to grow at a CAGR of 29.90% from 2025 to 2032.
Revenue, 2024 (USD Million)
628.73
Forecast, 2032 (USD Million)
2,732.61
CAGR, 2024 - 2032
29.90%
Report Coverage
U.S.
U.S. CRISPR Gene Detection and Diagnostic Market 2018-2032 USD Million
U.S. CRISPR Gene Detection and Diagnostic Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 628.73 USD Million
- Projected Market Size (2032): 2,732.61 USD Million
- CAGR (2025-2032): 29.90%
Key Findings of U.S. CRISPR Gene Detection and Diagnostic Market
- The U.S. CRISPR Gene Detection and Diagnostic Market was valued at 628.73 USD Million in 2024.
- The U.S. CRISPR Gene Detection and Diagnostic Market is likely to grow at a CAGR of 29.90% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Class-2 Single CrRNA-Binding Protein in Class Segment accounted for the largest share of the market with a revenue of 573.65 USD Million
- The fastest growing segment CRRNA in Workflow Segment grew Fastest with a CAGR of 35.07% during the forecast period from 2024 to 2032.
U.S. CRISPR Gene Detection and Diagnostic Market Scope
U.S. CRISPR Gene Detection and Diagnostic Market Segmentation & Scope
Class
- Class-1 Multiple Effector Proteins
- Class-2 Single CrRNA-Binding Protein
Products and Services
- Services
- Products
Application
- Others
- Drug Discovery
- Genome Engineering
- Agricultural Applications
- Biomedical Diagnostics
Workflow
- Sensing
- Sample Preparation
- Pre-Amplification
- Cas Enzyme
- CRRNA
End User
- Others
- Hospitals
- Diagnostic Centers
- Academic and Research Institutes
- Biotechnology Companies
Distribution Channel
- Retail Sales
- Direct Tender
U.S. CRISPR Gene Detection and Diagnostic Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2021 |
| Unit | Revenue in USD Million |
| Market Value in 2024 | 628.73 USD Million |
| Market Value in 2032 | 2,732.61 USD Million |
| CAGR (2025-2032) | 29.90% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Class,Products and Services,Application,Workflow,End User,Distribution Channel |
Regional Insights:
-
Leading Market (2024-2032): U.S., leading in terms of revenue 628.73 USD Million in 2024
- Key Country: U.S., leading in terms of revenue with value of 628.73 USD Million in 2024.
Segments and Scope
-
U.S. CRISPR Gene Detection and Diagnostic Market to 2032, By Class
- Class-2 Single CrRNA-Binding Protein is the largest segment in U.S. CRISPR Gene Detection and Diagnostic Market to 2032 with a revenue of 573.65 USD Million in the year 2024.
- Class-2 Single CrRNA-Binding Protein is the Fastest growing segment in U.S. CRISPR Gene Detection and Diagnostic Market to 2032 with a Growth rate of 30.90 % in forecast period 2025-2032.
-
U.S. CRISPR Gene Detection and Diagnostic Market to 2032, By Products and Services
- Products is the largest segment in U.S. CRISPR Gene Detection and Diagnostic Market to 2032 with a revenue of 416.82 USD Million in the year 2024.
- Products is the Fastest growing segment in U.S. CRISPR Gene Detection and Diagnostic Market to 2032 with a Growth rate of 31.08 % in forecast period 2025-2032.
-
U.S. CRISPR Gene Detection and Diagnostic Market to 2032, By Application
- Biomedical Diagnostics is the largest segment in U.S. CRISPR Gene Detection and Diagnostic Market to 2032 with a revenue of 363.33 USD Million in the year 2024.
- Biomedical Diagnostics is the Fastest growing segment in U.S. CRISPR Gene Detection and Diagnostic Market to 2032 with a Growth rate of 33.43 % in forecast period 2025-2032.
-
U.S. CRISPR Gene Detection and Diagnostic Market to 2032, By Workflow
- CRRNA is the largest segment in U.S. CRISPR Gene Detection and Diagnostic Market to 2032 with a revenue of 206.08 USD Million in the year 2024.
- CRRNA is the Fastest growing segment in U.S. CRISPR Gene Detection and Diagnostic Market to 2032 with a Growth rate of 35.07 % in forecast period 2025-2032.
-
U.S. CRISPR Gene Detection and Diagnostic Market to 2032, By End User
- Biotechnology Companies is the largest segment in U.S. CRISPR Gene Detection and Diagnostic Market to 2032 with a revenue of 279.67 USD Million in the year 2024.
- Biotechnology Companies is the Fastest growing segment in U.S. CRISPR Gene Detection and Diagnostic Market to 2032 with a Growth rate of 34.53 % in forecast period 2025-2032.
-
U.S. CRISPR Gene Detection and Diagnostic Market to 2032, By Distribution Channel
- Direct Tender is the largest segment in U.S. CRISPR Gene Detection and Diagnostic Market to 2032 with a revenue of 267.53 USD Million in the year 2024.
- Direct Tender is the Fastest growing segment in U.S. CRISPR Gene Detection and Diagnostic Market to 2032 with a Growth rate of 33.49 % in forecast period 2025-2032.
U.S. CRISPR Gene Detection and Diagnostic Market Company Share Analysis
| Company Name |
|
||
| Merck KGaA | |||
| Thermo Fisher Scientific Inc. | |||
| Agilent Technologies, Inc. | |||
| 10x Genomics | |||
| GenScript | |||
U.S. CRISPR Gene Detection and Diagnostic Market Geographical Sales Distribution, 2018-2032 USD Million
U.S. CRISPR Gene Detection and Diagnostic Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The U.S. CRISPR Gene Detection and Diagnostic Market is segmented based on Segmentation Class,Products and Services,Application,Workflow,End User,Distribution Channel.
U.S. CRISPR Gene Detection and Diagnostic Market was valued at USD 628.73(Revenue in USD Million) in 2021.
U.S. CRISPR Gene Detection and Diagnostic Market is projected to grow at a CAGR of 29.90% during the forecast period of 2024 to 2032.
The Class-2 Single CrRNA-Binding Protein segment is expected to dominate the U.S. CRISPR Gene Detection and Diagnostic Market, holding a largest market share of 573.65 USD Million in 2024
U.S. CRISPR Gene Detection and Diagnostic Market Scope
U.S. CRISPR Gene Detection and Diagnostic Market Segmentation & Scope
Class
- Class-1 Multiple Effector Proteins
- Class-2 Single CrRNA-Binding Protein
Products and Services
- Services
- Products
Application
- Others
- Drug Discovery
- Genome Engineering
- Agricultural Applications
- Biomedical Diagnostics
Workflow
- Sensing
- Sample Preparation
- Pre-Amplification
- Cas Enzyme
- CRRNA
End User
- Others
- Hospitals
- Diagnostic Centers
- Academic and Research Institutes
- Biotechnology Companies
Distribution Channel
- Retail Sales
- Direct Tender
Frequently Asked Questions
The U.S. CRISPR Gene Detection and Diagnostic Market is segmented based on Segmentation Class,Products and Services,Application,Workflow,End User,Distribution Channel.
U.S. CRISPR Gene Detection and Diagnostic Market was valued at USD 628.73(Revenue in USD Million) in 2021.
U.S. CRISPR Gene Detection and Diagnostic Market is projected to grow at a CAGR of 29.90% during the forecast period of 2024 to 2032.
The estimated market value of the U.S. CRISPR Gene Detection and Diagnostic Market for final year is USD 2,732.61 (USD Million).
U.S. CRISPR Gene Detection and Diagnostic Market Company Profiling
Frequently Asked Questions
The U.S. CRISPR Gene Detection and Diagnostic Market is segmented based on Segmentation Class,Products and Services,Application,Workflow,End User,Distribution Channel.
U.S. CRISPR Gene Detection and Diagnostic Market was valued at USD 628.73(Revenue in USD Million) in 2021.
U.S. CRISPR Gene Detection and Diagnostic Market is projected to grow at a CAGR of 29.90% during the forecast period of 2024 to 2032.
The estimated market value of the U.S. CRISPR Gene Detection and Diagnostic Market for final year is USD 2,732.61 (USD Million).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.